| Andrew J. Schroettner, Mdsc | |
|
888 Thackeray Trl Suite 211 Oconomowoc WI 53066-4342 | |
| (262) 567-1122 | |
| (262) 567-1481 |
| Full Name | Andrew J. Schroettner, Mdsc |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 888 Thackeray Trl, Oconomowoc, Wisconsin |
| Authorized Official Name and Position | Andrew J Schroettner (OWNER) |
| Authorized Official Contact | 2625671122 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Andrew J. Schroettner, Mdsc 888 Thackeray Trl Suite 211 Oconomowoc WI 53066-4342 Ph: (262) 567-1122 | Andrew J. Schroettner, Mdsc 888 Thackeray Trl Suite 211 Oconomowoc WI 53066-4342 Ph: (262) 567-1122 |
| NPI Number | 1790992170 |
|---|---|
| Provider Enumeration Date | 05/16/2007 |
| Last Update Date | 08/22/2020 |
| Medicare PECOS PAC ID | 7416044474 |
|---|---|
| Medicare Enrollment ID | O20071107000711 |
News Archive
Significant weaknesses undermine the global community's abilities to prevent, detect early, and respond efficiently to potentially deadly species-crossing microbes, such as the pandemic H1N1 influenza virus sweeping the globe, says a new report from the Institute of Medicine and National Research Council. The report provides a detailed plan for establishing and funding a comprehensive, globally coordinated system to identify novel zoonotic disease threats as early as possible wherever they arise so appropriate measures can be taken to prevent significant numbers of human illnesses and deaths, and livestock losses.
OSI Pharmaceuticals, Inc. today confirmed that Astellas Pharma Inc. has commenced an unsolicited tender offer to acquire all outstanding common shares of OSI for $52.00 per share in cash.
Accelitech LLC, the leader in the development and full-cycle management of technology-driven cancer treatment programs, is pleased to announce its inaugural proton therapy project. The treatment center project, now under development, is the latest in Accelitech's ongoing effort to bring leading treatment technologies to more patients through joint-venture partnerships with physicians and hospitals.
Efforts by Indonesia to avoid food shortages by increasing its rice production have received an important boost with the signing of a new agreement to help the nation's millions of poor rice farmers with new technologies.
Sangamo BioSciences, Inc. announced today that data from clinical, preclinical and research-stage programs focused on the development of zinc finger DNA-binding protein Therapeutics were described in twenty presentations given by Sangamo scientists and collaborators at the 14th Annual Meeting of the American Society of Gene and Cell Therapy.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790992170 | NPI | - | NPPES |
| 31941000 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 34568 (Wisconsin) | Primary |
| Provider Name | Andrew J Schroettner |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1043245459 PECOS PAC ID: 2769378611 Enrollment ID: I20040226000487 |
News Archive
Significant weaknesses undermine the global community's abilities to prevent, detect early, and respond efficiently to potentially deadly species-crossing microbes, such as the pandemic H1N1 influenza virus sweeping the globe, says a new report from the Institute of Medicine and National Research Council. The report provides a detailed plan for establishing and funding a comprehensive, globally coordinated system to identify novel zoonotic disease threats as early as possible wherever they arise so appropriate measures can be taken to prevent significant numbers of human illnesses and deaths, and livestock losses.
OSI Pharmaceuticals, Inc. today confirmed that Astellas Pharma Inc. has commenced an unsolicited tender offer to acquire all outstanding common shares of OSI for $52.00 per share in cash.
Accelitech LLC, the leader in the development and full-cycle management of technology-driven cancer treatment programs, is pleased to announce its inaugural proton therapy project. The treatment center project, now under development, is the latest in Accelitech's ongoing effort to bring leading treatment technologies to more patients through joint-venture partnerships with physicians and hospitals.
Efforts by Indonesia to avoid food shortages by increasing its rice production have received an important boost with the signing of a new agreement to help the nation's millions of poor rice farmers with new technologies.
Sangamo BioSciences, Inc. announced today that data from clinical, preclinical and research-stage programs focused on the development of zinc finger DNA-binding protein Therapeutics were described in twenty presentations given by Sangamo scientists and collaborators at the 14th Annual Meeting of the American Society of Gene and Cell Therapy.
› Verified 8 days ago
News Archive
Significant weaknesses undermine the global community's abilities to prevent, detect early, and respond efficiently to potentially deadly species-crossing microbes, such as the pandemic H1N1 influenza virus sweeping the globe, says a new report from the Institute of Medicine and National Research Council. The report provides a detailed plan for establishing and funding a comprehensive, globally coordinated system to identify novel zoonotic disease threats as early as possible wherever they arise so appropriate measures can be taken to prevent significant numbers of human illnesses and deaths, and livestock losses.
OSI Pharmaceuticals, Inc. today confirmed that Astellas Pharma Inc. has commenced an unsolicited tender offer to acquire all outstanding common shares of OSI for $52.00 per share in cash.
Accelitech LLC, the leader in the development and full-cycle management of technology-driven cancer treatment programs, is pleased to announce its inaugural proton therapy project. The treatment center project, now under development, is the latest in Accelitech's ongoing effort to bring leading treatment technologies to more patients through joint-venture partnerships with physicians and hospitals.
Efforts by Indonesia to avoid food shortages by increasing its rice production have received an important boost with the signing of a new agreement to help the nation's millions of poor rice farmers with new technologies.
Sangamo BioSciences, Inc. announced today that data from clinical, preclinical and research-stage programs focused on the development of zinc finger DNA-binding protein Therapeutics were described in twenty presentations given by Sangamo scientists and collaborators at the 14th Annual Meeting of the American Society of Gene and Cell Therapy.
› Verified 8 days ago
Mark H Rossing Mdsc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 888 Thackeray Trl, Suite 211, Oconomowoc, WI 53066 Phone: 262-567-1122 Fax: 262-567-1481 | |
Joanne Berthelsen Lcsw Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 830 Armour Rd Ste 2, Oconomowoc, WI 53066 Phone: 262-235-2350 Fax: 235-804-8132 | |
South Street Clinic Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 416 W South St, Oconomowoc, WI 53066 Phone: 262-567-7673 Fax: 262-567-3097 | |
Secure Beginnings, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: N52w35634 W Lake Dr, Oconomowoc, WI 53066 Phone: 262-901-5881 | |
A New Day Psychological Services Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 970 S Silver Lake St, Suite 103, Oconomowoc, WI 53066 Phone: 262-567-7900 Fax: 262-567-7908 | |
Bethany Christian Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1331 Capitol Dr, Oconomowoc, WI 53066 Phone: 262-547-6557 Fax: 262-547-3644 | |
Roots Counseling And Consulting, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: W340n8809 Townline Rd, Oconomowoc, WI 53066 Phone: 262-442-8433 |